# PD-1 Knockout Engineered T Cells for Advanced Esophageal Cancer

> **NCT03081715** · NA · COMPLETED · sponsor: **Hangzhou Cancer Hospital** · enrollment: 16 (actual)

## Conditions studied

- Esophageal Cancer

## Interventions

- **OTHER:** PD-1 Knockout T Cells

## Key facts

- **NCT ID:** NCT03081715
- **Lead sponsor:** Hangzhou Cancer Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-03-14
- **Primary completion:** 2018-01-23
- **Final completion:** 2018-02-28
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2019-06-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03081715

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03081715, "PD-1 Knockout Engineered T Cells for Advanced Esophageal Cancer". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT03081715. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*